For example, imatinib, a tyrosine kinase inhibitor used in chronic myeloid leukemia (CML), is transported into cells via the organic human cation transporter 1 (hOCT1) [52]. This evidence concerns the gene SLC22A1 and chronic myelogenous leukemia, BCR-ABL1 positive.